These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 38283805)
1. An overview of multiple myeloma: A monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities. Abduh MS Saudi J Biol Sci; 2024 Feb; 31(2):103920. PubMed ID: 38283805 [TBL] [Abstract][Full Text] [Related]
2. A Study on Free Light Chain Assay and Serum Immunofixation Electrophoresis for the Diagnosis of Monoclonal Gammopathies. Kuriakose E; Narayanan Unni Cheppayil S; Kuzhikandathil Narayanan S; Vasudevan A Indian J Clin Biochem; 2019 Jan; 34(1):76-81. PubMed ID: 30728676 [TBL] [Abstract][Full Text] [Related]
3. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy]. Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822 [No Abstract] [Full Text] [Related]
4. Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results. Singh G J Clin Med Res; 2017 Aug; 9(8):671-679. PubMed ID: 28725315 [TBL] [Abstract][Full Text] [Related]
5. Advances in biology and therapy of multiple myeloma. Barillé-Nion S; Barlogie B; Bataille R; Bergsagel PL; Epstein J; Fenton RG; Jacobson J; Kuehl WM; Shaughnessy J; Tricot G Hematology Am Soc Hematol Educ Program; 2003; ():248-78. PubMed ID: 14633785 [TBL] [Abstract][Full Text] [Related]
6. Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Ho M; Patel A; Goh CY; Moscvin M; Zhang L; Bianchi G Leukemia; 2020 Dec; 34(12):3111-3125. PubMed ID: 33046818 [TBL] [Abstract][Full Text] [Related]
7. Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. Damasceno D; Almeida J; Teodosio C; Sanoja-Flores L; Mayado A; Pérez-Pons A; Puig N; Arana P; Paiva B; Solano F; Romero A; Matarraz S; van den Bossche WBL; Flores-Montero J; Durie B; van Dongen JJM; Orfao A Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33810169 [TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma. An update on diagnosis and management. Kyle RA Acta Oncol; 1990; 29(1):1-8. PubMed ID: 2178649 [TBL] [Abstract][Full Text] [Related]
9. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back. Bianchi G; Anderson KC CA Cancer J Clin; 2014; 64(6):422-44. PubMed ID: 25266555 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma. van de Donk NW; Kamps S; Mutis T; Lokhorst HM Leukemia; 2012 Feb; 26(2):199-213. PubMed ID: 21852787 [TBL] [Abstract][Full Text] [Related]
11. MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology. Mateos MV; Landgren O Cancer Treat Res; 2016; 169():3-12. PubMed ID: 27696254 [TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma. Kawamura K Int J Hematol; 2023 Aug; 118(2):193-200. PubMed ID: 37060508 [TBL] [Abstract][Full Text] [Related]
19. Development of early treatment strategies for high-risk myeloma precursor disease in the future. Landgren O; Rajkumar SV Semin Hematol; 2011 Jan; 48(1):66-72. PubMed ID: 21232660 [TBL] [Abstract][Full Text] [Related]